Cancer Risks for PMS2-Associated Lynch Syndrome.
Sanne W Ten Broeke,Heleen M van der Klift,Carli M J Tops,Stefan Aretz,Inge Bernstein,Daniel D Buchanan,Albert de la Chapelle,Gabriel Capella,Mark Clendenning,Christoph Engel,Steven Gallinger,Encarna Gomez Garcia,Jane C Figueiredo,Robert Haile,Heather L Hampel,John L Hopper,Nicoline Hoogerbrugge,Magnus von Knebel Doeberitz,Loic Le Marchand,Tom G W Letteboer,Mark A Jenkins,Annika Lindblom,Noralane M Lindor,Arjen R Mensenkamp,Pål Møller,Polly A Newcomb,Theo A M van Os,Rachel Pearlman,Marta Pineda,Nils Rahner,Egbert J W Redeker,Maran J W Olderode-Berends,Christophe Rosty,Hans K Schackert,Rodney Scott,Leigha Senter,Liesbeth Spruijt,Verena Steinke-Lange,Manon Suerink,Stephen Thibodeau,Yvonne J Vos,Anja Wagner,Ingrid Winship,Frederik J Hes,Hans F A Vasen,Juul T Wijnen,Maartje Nielsen,Aung Ko Win Journal of clinical oncology official journal of the American Society of Clinical Oncology（2018）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper